Orion Continues Patent Battle Against Generic Stalevo
Pharmaceutical company Orion Corp. shot off a lawsuit Monday in an effort to stop Wockhardt Ltd. from marketing a generic version of Stalevo, a treatment for Parkinson's disease, the latest in...To view the full article, register now.
Already a subscriber? Click here to view full article